CYTOFLEX

Device Beckman Coulter, Inc.
Total Payments
$2.1M
Transactions
43
Doctors
11
Companies
1

Payment Trends by Year

Year Amount Transactions Doctors
2024 $477,214 2 0
2023 $498,125 8 2
2022 $561,274 2 1
2021 $512,682 3 1
2019 $313.92 5 2
2018 $5,422 23 8

Payments by Nature

Nature of Payment Amount Transactions Share
Royalty or License $2.0M 8 99.6%
Travel and Lodging $4,984 1 0.2%
Education $1,621 1 0.1%
Food and Beverage $1,073 33 0.1%

Top Doctors Receiving Payments for CYTOFLEX

Doctor Specialty Location Total Records
Unknown Boston, MA $1.4M 7
, MD Hematology & Oncology Seattle, WA $617,470 2
, M.D., PH.D Specialist Seattle, WA $5,811 24
, MD Pediatric Hematology-Oncology Indianapolis, IN $95.10 2
, M.D., PH.D Clinical Pathology/Laboratory Medicine New Haven, CT $27.70 1
, MD Hematology & Oncology Baltimore, MD $20.85 1
, MD Internal Medicine Lexington, KY $19.97 1
, MD Surgery Lexington, KY $19.97 1
, MD, PHD Neurology Lexington, KY $19.97 1
, M.D Hematology Seattle, WA $19.38 1
, D.O Family Medicine Hugo, OK $11.96 1
, M.D., PH.D Specialist Irvine, CA $10.63 1

About CYTOFLEX

CYTOFLEX is a device associated with $2.1M in payments to 11 healthcare providers, recorded across 43 transactions in the CMS Open Payments database. The primary manufacturer is Beckman Coulter, Inc..

Payment data is available from 2018 to 2024. In 2024, $477,214 was paid across 2 transactions to 0 doctors.

The most common payment nature for CYTOFLEX is "Royalty or License" ($2.0M, 99.6% of total).